[DPHARMA] YoY Quarter Result on 31-Dec-2013 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
26-Feb-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
31-Dec-2013 [#4]
Profit Trend
QoQ- 37.24%
YoY- 55.27%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Quarter Result
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Revenue 74,033 89,401 51,024 45,734 35,378 33,036 32,195 14.87%
PBT 6,299 17,529 13,921 9,160 9,000 7,836 8,607 -5.06%
Tax 2,532 0 0 153 -3,002 -1,507 7 166.68%
NP 8,831 17,529 13,921 9,313 5,998 6,329 8,614 0.41%
-
NP to SH 8,428 15,335 11,119 9,313 5,998 6,329 8,614 -0.36%
-
Tax Rate -40.20% 0.00% 0.00% -1.67% 33.36% 19.23% -0.08% -
Total Cost 65,202 71,872 37,103 36,421 29,380 26,707 23,581 18.45%
-
Net Worth 454,703 270,177 192,951 181,818 169,359 163,776 156,744 19.40%
Dividend
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Div 11,158 9,172 20,128 18,737 14,576 20,125 152 104.49%
Div Payout % 132.40% 59.82% 181.02% 201.19% 243.02% 317.98% 1.77% -
Equity
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Net Worth 454,703 270,177 192,951 181,818 169,359 163,776 156,744 19.40%
NOSH 278,959 278,959 138,813 138,792 138,819 138,793 138,711 12.33%
Ratio Analysis
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
NP Margin 11.93% 19.61% 27.28% 20.36% 16.95% 19.16% 26.76% -
ROE 1.85% 5.68% 5.76% 5.12% 3.54% 3.86% 5.50% -
Per Share
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
RPS 26.54 53.61 36.76 32.95 25.48 23.80 23.21 2.25%
EPS 3.41 9.19 8.01 6.71 4.32 4.56 6.21 -9.49%
DPS 4.00 5.50 14.50 13.50 10.50 14.50 0.11 81.91%
NAPS 1.63 1.62 1.39 1.31 1.22 1.18 1.13 6.29%
Adjusted Per Share Value based on latest NOSH - 138,792
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
RPS 7.70 9.29 5.30 4.75 3.68 3.43 3.35 14.86%
EPS 0.88 1.59 1.16 0.97 0.62 0.66 0.90 -0.37%
DPS 1.16 0.95 2.09 1.95 1.52 2.09 0.02 96.62%
NAPS 0.4727 0.2809 0.2006 0.189 0.1761 0.1703 0.1629 19.40%
Price Multiplier on Financial Quarter End Date
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Date 30/12/16 31/12/15 31/12/14 31/12/13 31/12/12 30/12/11 30/12/10 -
Price 1.98 2.62 2.50 2.58 2.13 2.02 2.39 -
P/RPS 7.46 4.89 6.80 7.83 8.36 8.49 10.30 -5.22%
P/EPS 65.54 28.49 31.21 38.45 49.30 44.30 38.49 9.26%
EY 1.53 3.51 3.20 2.60 2.03 2.26 2.60 -8.45%
DY 2.02 2.10 5.80 5.23 4.93 7.18 0.05 85.13%
P/NAPS 1.21 1.62 1.80 1.97 1.75 1.71 2.12 -8.91%
Price Multiplier on Announcement Date
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Date 24/02/17 23/02/16 24/02/15 26/02/14 25/02/13 22/02/12 23/02/11 -
Price 2.23 2.61 2.92 2.60 2.17 2.12 2.45 -
P/RPS 8.40 4.87 7.94 7.89 8.51 8.91 10.56 -3.73%
P/EPS 73.81 28.39 36.45 38.75 50.22 46.49 39.45 10.99%
EY 1.35 3.52 2.74 2.58 1.99 2.15 2.53 -9.93%
DY 1.79 2.11 4.97 5.19 4.84 6.84 0.04 88.31%
P/NAPS 1.37 1.61 2.10 1.98 1.78 1.80 2.17 -7.37%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment